Unlocking the Future: MHRA Invests £3.6M in AI Airlock Expansion
The MHRA secures multi-year funding to expand its groundbreaking AI Airlock programme, cementing its position as a leader in innovation and regulatory technology.
The Medicines and Healthcare products Regulatory Agency (MHRA) is taking a major leap forward in the realm of artificial intelligence (AI) and regulatory technology. The agency has secured a substantial £3.6 million funding boost over the next three years to expand its pioneering AI Airlock programme, solidifying its position as a global leader in this transformative field.
The AI Airlock is a revolutionary initiative that harnesses the power of AI to streamline and optimize the regulatory approval process for new medicines and healthcare products. By leveraging advanced machine learning algorithms and natural language processing, the AI Airlock aims to accelerate the evaluation and decision-making process, ultimately bringing innovative therapies and technologies to market more efficiently.
{{IMAGE_PLACEHOLDER}}Source: UK Government
